PT2890394T - Proteínas estabilizadas para imunização contra staphylococcus aureus - Google Patents

Proteínas estabilizadas para imunização contra staphylococcus aureus

Info

Publication number
PT2890394T
PT2890394T PT13753327T PT13753327T PT2890394T PT 2890394 T PT2890394 T PT 2890394T PT 13753327 T PT13753327 T PT 13753327T PT 13753327 T PT13753327 T PT 13753327T PT 2890394 T PT2890394 T PT 2890394T
Authority
PT
Portugal
Prior art keywords
staphylococcus aureus
against staphylococcus
immunising against
stabilised
proteins
Prior art date
Application number
PT13753327T
Other languages
English (en)
Inventor
Grandi Guido
Bagnoli Fabio
Falugi Fabiana
Mariani Massimo
Nissum Mikkel
Pallaoro Michele
Savino Silvana
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of PT2890394T publication Critical patent/PT2890394T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
PT13753327T 2012-08-31 2013-08-29 Proteínas estabilizadas para imunização contra staphylococcus aureus PT2890394T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261695723P 2012-08-31 2012-08-31

Publications (1)

Publication Number Publication Date
PT2890394T true PT2890394T (pt) 2019-07-15

Family

ID=49036594

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13753327T PT2890394T (pt) 2012-08-31 2013-08-29 Proteínas estabilizadas para imunização contra staphylococcus aureus

Country Status (15)

Country Link
US (1) US9926344B2 (pt)
EP (1) EP2890394B1 (pt)
JP (1) JP6435261B2 (pt)
CN (2) CN110563818A (pt)
CY (1) CY1121944T1 (pt)
DK (1) DK2890394T3 (pt)
ES (1) ES2737024T3 (pt)
HR (1) HRP20191166T1 (pt)
HU (1) HUE044211T2 (pt)
LT (1) LT2890394T (pt)
PL (1) PL2890394T3 (pt)
PT (1) PT2890394T (pt)
SI (1) SI2890394T1 (pt)
TR (1) TR201910573T4 (pt)
WO (1) WO2014033190A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014CN02152A (pt) * 2011-09-01 2015-09-04 Novartis Ag
MX2016012538A (es) 2014-03-26 2016-12-14 Glaxosmithkline Biologicals Sa Antigenos estafilococicos mutantes.
KR20190072667A (ko) 2016-11-14 2019-06-25 리락 솔루션즈, 인크. 코팅된 이온 교환 입자를 이용한 리튬 추출
JP6916042B2 (ja) * 2017-06-09 2021-08-11 株式会社明治 抗原特異的インターフェロンγ産生促進用組成物
AR112663A1 (es) 2017-08-02 2019-11-27 Lilac Solutions Inc Extracción de litio con perlas porosas de intercambio iónico
EP3759257A4 (en) 2018-02-28 2021-11-24 Lilac Solutions, Inc. ION EXCHANGE REACTOR WITH PARTICLE TRAPS FOR LITHIUM EXTRACTION
CA3166921A1 (en) 2020-01-09 2021-07-15 Lilac Solutions, Inc. Process for separating undesirable metals
CN111595658B (zh) * 2020-06-06 2023-11-14 宾傲 一种提取细胞中蛋白的裂解液及其制备方法
JP2023529444A (ja) 2020-06-09 2023-07-10 ライラック ソリューションズ，インク． スケール物質存在下におけるリチウム抽出
EP4247759A1 (en) 2020-11-20 2023-09-27 Lilac Solutions, Inc. Lithium production with volatile acid
WO2022226219A1 (en) 2021-04-23 2022-10-27 Lilac Solutions, Inc. Ion exchange devices for lithium extraction

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS624300A (ja) 1985-06-28 1987-01-10 Dai Ichi Seiyaku Co Ltd 改良型ヒトガンマインタ−フエロンおよびその製造方法
DE68929273T2 (de) * 1988-08-24 2001-07-05 American Cyanamid Co Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
US5874238A (en) * 1993-02-26 1999-02-23 Immtech International Inc. Mutant protein and methods and materials for making and using it
WO1995011700A1 (en) 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
US6080725A (en) 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
US7306931B2 (en) * 2000-05-16 2007-12-11 Bolder Biotechnology, Inc. Method for refolding proteins containing free cysteine residues
WO1999056776A2 (en) 1998-05-07 1999-11-11 Corixa Corporation Adjuvant composition and methods for its use
PT1126876E (pt) 1998-10-16 2007-04-30 Glaxosmithkline Biolog Sa Sistemas adjuvantes e vacinas
GB9825421D0 (en) * 1998-11-19 1999-01-13 Isis Innovation Process for oxidising terpenes
EP1150918B1 (en) 1999-02-03 2004-09-15 Biosante Pharmaceuticals, Inc. Method of manufacturing therapeutic calcium phosphate particles
KR100382239B1 (ko) 2000-02-17 2003-04-26 주식회사 엘지생명과학 황색 포도상 구균의 변이 독소 에스이씨-에스이알, 그것의발현벡터 및 숙주세포, 그 생산방법 및 백신제조방법
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
KR20070008625A (ko) 2004-04-05 2007-01-17 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
US20060228369A1 (en) 2005-04-11 2006-10-12 Program For Appropriate Technology In Health Stabilization and preservation of temperature-sensitive vaccines
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
EP2471550A1 (en) 2005-10-07 2012-07-04 Health Protection Agency Proteins with improved solubility and methods for producing and using same
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
EP2368569A3 (en) 2006-01-18 2012-05-02 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
KR101151202B1 (ko) 2006-10-12 2012-06-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 수중유 에멀젼 애주번트를 포함하는 백신
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
JP5830009B2 (ja) 2009-04-14 2015-12-09 ノバルティス アーゲー Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓに対して免疫化するための組成物
AU2010290896B2 (en) 2009-09-02 2014-07-03 Glaxosmithkline Biologicals S.A. Immunogenic compositions including TLR activity modulators
US8974799B2 (en) * 2009-09-30 2015-03-10 Novartis Ag Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides
DK2493498T3 (en) * 2009-10-30 2017-05-08 Glaxosmithkline Biologicals Sa Purification of Staphylococcus aureus type 5 and type 8 capsule saccharides
JP2011212008A (ja) * 2010-03-16 2011-10-27 Olympus Corp 蛍光タンパク質およびｐＨ測定方法
IN2014CN02152A (pt) * 2011-09-01 2015-09-04 Novartis Ag
EP2793939A1 (en) 2011-12-23 2014-10-29 Novartis AG Stable compositions for immunising against staphylococcus aureus

Also Published As

Publication number Publication date
ES2737024T3 (es) 2020-01-09
LT2890394T (lt) 2019-07-25
DK2890394T3 (da) 2019-07-15
JP6435261B2 (ja) 2018-12-05
CY1121944T1 (el) 2020-10-14
HUE044211T2 (hu) 2019-10-28
CN104619336A (zh) 2015-05-13
PL2890394T3 (pl) 2019-12-31
SI2890394T1 (sl) 2019-06-28
EP2890394A1 (en) 2015-07-08
CN110563818A (zh) 2019-12-13
US20150203542A1 (en) 2015-07-23
HRP20191166T1 (hr) 2019-10-04
EP2890394B1 (en) 2019-05-01
WO2014033190A1 (en) 2014-03-06
JP2015528455A (ja) 2015-09-28
TR201910573T4 (tr) 2019-08-21
US9926344B2 (en) 2018-03-27

Similar Documents

Publication Publication Date Title
LT2890394T (lt) Stabilizuoti baltymai skirti imunizavimui nuo staphylococcus aureus
EP2816886A4 (en) AUTOMATIC LAWNMOWER
PL2912020T3 (pl) Fungicydy podstawione tolilem
PL3295781T3 (pl) Kosiarka robotyczna
GB201206598D0 (en) Herbicidal compounds
HK1206031A1 (en) Antibacterial compounds
EP2817812A4 (en) ROBOTIC TURF MOWER
GB201205657D0 (en) Herbicidal compounds
HK1209585A1 (en) Vermin controlling agent
GB201218813D0 (en) Antimicrobial peptides
HK1215031A1 (zh) 抗微生物劑
GB201205654D0 (en) Herbicidal compounds
HK1210954A1 (en) Antibacterial compounds
ZA201504362B (en) Pest control agent
GB201211202D0 (en) Antimicrobial compounds
EP2773370A4 (en) PROTECTIVE VACCINE BASED ON THE STAPHYLOCOCCUS AUREUS PROTEIN SA2451
EP2773655A4 (en) STAPHYLOCOCUS AUREUS SA2074 PROTEIN PROTECTIVE VACCINE
IL239207A0 (en) Antibacterial compounds
GB201211203D0 (en) Antimicrobial compounds
GB201217868D0 (en) Staphyolococcus aureus antigens
EP2872173A4 (en) STAPHYLOCOCCUS AUREUS SA2493 PROTEIN PROTECTIVE VACCINE
GB201219148D0 (en) Herbicidal compounds
GB201211736D0 (en) Pest control
GB201211002D0 (en) Pest control
GB201205660D0 (en) Herbicidal compounds